Harel Insurance Investments & Financial Services’s Moleculin Biotech MBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-667	Closed	-$136K	–	832
2021 Q1	$136K	Buy	+667	New	+$136K	﹤0.01%	606